AASLD Practice Guideline
Management of hepatocellular carcinoma: An update †‡
Potential conflict of interest: Dr. Bruix advises, consults for, serves on the speaker's bureau of, and received grants from Bayer. Dr. Bruix consults for Biocompatibles, GlaxoSmithKline, Kowa, Novartis, and Arqule. Dr. Bruix also advises and consults for Bristol-Myers Squibb. Dr. Sherman serves on the speakers' bureau of Bayer
Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms
The full text of this practice guideline is available at: http://www.aasld.org/publications/practice-guidelines-0.
No abstract is available for this article.